In this article, Hervé Sibillat, general manager, ADM-SIO, discusses the important considerations in managing the natural variability of plant-based pharmaceutical ingredients.
Traditionally, excipient selection has been performed using trial-and-error based methodologies, which are time-consuming and expensive. In this article, Dr Amjad Alhalaweh, PhD, formulation scientist, Recipharm, discusses a new method, HTS
In the second part of the CPhI Worldwide Annual Report it has been revealed that the trend towards the increased use of modern manufacturing processes and quality systems is occurring very slowly and the current drugs pipeline is discouraging.
Demand for high potent active pharmaceutical ingredients is driving the need for high potency handling capabilities. Here, Mike Avraam, global product manager for ChargePoint PharmaSafe, ChargePoint Technology, discusses this growing sector in detail
CPhI has released the findings of its 2017 India Pharma Market Report, identifying improved international repute of India but an urgent call for government support for investment in active pharmaceutical ingredient (API) facilities.
Lyophilisation is crucial in the creation of pharmaceutical ingredients with an extended shelf life, however, current methods can still be costly and time consuming. Hosokawa Micron reveals its new method of contained active freeze drying
Doug Millington-Smith, principal applications specialist at powder characterisation company Freeman Technology, considers the value of multivariate powder characterisation as a solution to the demand for comprehensive data.
Jonathan Knight, VP New Product Development at Cambrex, dissects the route used to manufacture APIs, highlighting those steps that can make a process ideal.
It has been announced that Chemische Fabrik Budenheim site in Budenheim, Germany, has recently been awarded an EXCiPACT GMP/GDP certificate from SGS — one of EXCiPACT’s internationally recognised certification bodies.
